Sun Pharma Advanced Research Company Ltd. - Product Pipeline Review - 2016

  • ID: 3821629
  • Company Profile
  • 51 pages
  • Global Markets Direct
1 of 4
Sun Pharma Advanced Research Company Ltd. - Product Pipeline Review - 2016

Summary

‘Sun Pharma Advanced Research Company Ltd. - Product Pipeline Review - 2016’, provides an overview of the Sun Pharma Advanced Research Company Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sun Pharma Advanced Research Company Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Sun Pharma Advanced Research Company Ltd.
- The report provides overview of Sun Pharma Advanced Research Company Ltd. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Sun Pharma Advanced Research Company Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Sun Pharma Advanced Research Company Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Sun Pharma Advanced Research Company Ltd.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Sun Pharma Advanced Research Company Ltd.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Sun Pharma Advanced Research Company Ltd.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Figures

Sun Pharma Advanced Research Company Ltd. Snapshot

Sun Pharma Advanced Research Company Ltd. Overview

Key Information

Key Facts

Sun Pharma Advanced Research Company Ltd. - Research and Development Overview

Key Therapeutic Areas

Sun Pharma Advanced Research Company Ltd. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Sun Pharma Advanced Research Company Ltd. - Pipeline Products Glance

Sun Pharma Advanced Research Company Ltd. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Filing rejected/Withdrawn Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Sun Pharma Advanced Research Company Ltd. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Sun Pharma Advanced Research Company Ltd. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Sun Pharma Advanced Research Company Ltd. - Drug Profiles

latanoprost

Product Description

Mechanism of Action

R&D Progress

baclofen ER

Product Description

Mechanism of Action

R&D Progress

tildrakizumab

Product Description

Mechanism of Action

R&D Progress

paclitaxel albumin free

Product Description

Mechanism of Action

R&D Progress

tizanidine hydrochloride ER

Product Description

Mechanism of Action

R&D Progress

SUNK-706

Product Description

Mechanism of Action

R&D Progress

(fluticasone propionate + salmeterol xinafoate)

Product Description

Mechanism of Action

R&D Progress

docetaxel

Product Description

Mechanism of Action

R&D Progress

octreotide acetate SR

Product Description

Mechanism of Action

R&D Progress

SUN-0597

Product Description

Mechanism of Action

R&D Progress

brimonidine tartrate

Product Description

Mechanism of Action

R&D Progress

hydrocodone bitartrate

Product Description

Mechanism of Action

R&D Progress

minocycline hydrochloride

Product Description

Mechanism of Action

R&D Progress

morphine sulfate

Product Description

Mechanism of Action

R&D Progress

oxycodone hydrochloride

Product Description

Mechanism of Action

R&D Progress

Gene Therapy for Ocular Diseases

Product Description

Mechanism of Action

R&D Progress

Sun Pharma Advanced Research Company Ltd. - Pipeline Analysis

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Target

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Route of Administration

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Molecule Type

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Mechanism of Action

Sun Pharma Advanced Research Company Ltd. - Recent Pipeline Updates

Sun Pharma Advanced Research Company Ltd. - Dormant Projects

Sun Pharma Advanced Research Company Ltd. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

baclofen ER

RBx-10558

SUN-0597

SUN-09 IR

SUN-09 Slow Release

SUN-1334H

SUN-44

SUNL-731

Sun Pharma Advanced Research Company Ltd. - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

Sun Pharma Advanced Research Company Ltd., Key Information

Sun Pharma Advanced Research Company Ltd., Key Facts

Sun Pharma Advanced Research Company Ltd. - Pipeline by Indication, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Stage of Development, 2016

Sun Pharma Advanced Research Company Ltd. - Monotherapy Products in Pipeline, 2016

Sun Pharma Advanced Research Company Ltd. - Combination Treatment Modalities in Pipeline, 2016

Sun Pharma Advanced Research Company Ltd. - Partnered Products in Pipeline, 2016

Sun Pharma Advanced Research Company Ltd. - Partnered Products/ Combination Treatment Modalities, 2016

Sun Pharma Advanced Research Company Ltd. - Pre-Registration, 2016

Sun Pharma Advanced Research Company Ltd. - Filing rejected/Withdrawn, 2016

Sun Pharma Advanced Research Company Ltd. - Phase III, 2016

Sun Pharma Advanced Research Company Ltd. - Phase II, 2016

Sun Pharma Advanced Research Company Ltd. - Phase I, 2016

Sun Pharma Advanced Research Company Ltd. - Preclinical, 2016

Sun Pharma Advanced Research Company Ltd. - Discovery, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Target, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Route of Administration, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Molecule Type, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Mechanism of Action, 2016

Sun Pharma Advanced Research Company Ltd. - Recent Pipeline Updates, 2016

Sun Pharma Advanced Research Company Ltd. - Dormant Developmental Projects,2016

Sun Pharma Advanced Research Company Ltd. - Discontinued Pipeline Products, 2016 47List of Figures

Sun Pharma Advanced Research Company Ltd. - Pipeline by Top 10 Indication, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Stage of Development, 2016

Sun Pharma Advanced Research Company Ltd. - Monotherapy Products in Pipeline, 2016

Sun Pharma Advanced Research Company Ltd. - Partnered Products in Pipeline, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Top 10 Target, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Route of Administration, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline by Molecule Type, 2016

Sun Pharma Advanced Research Company Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll